E. Chaffeensis Ab IgM

Sample type: Serum
<1:20
A negative result for Ehrlichia chaffeensis Ab (IgM) typically indicates the absence of detectable IgM antibodies against Ehrlichia chaffeensis in the patient's blood, suggesting that a recent or acute infection with this bacterium is unlikely. Since IgM antibodies are the first to be produced in response to an infection, usually appearing within the first couple of weeks, their absence often points to the lack of a current or recent infection with the pathogen responsible for human monocytic ehrlichiosis (HME). However, it's important to consider the timing of the test, as a very early test before antibody levels have risen, or a late test after antibody levels have declined, might also yield a negative result. Additionally, the sensitivity and specificity of the test and individual variations in immune response can affect results. Therefore, a negative E. Chaffeensis Ab (IgM) result, while suggestive of no recent infection, should be interpreted in the context of the patient's clinical symptoms, exposure history, and other diagnostic findings, and further testing may be warranted in some cases.
=>1:20
An elevated result for Ehrlichia chaffeensis Ab (IgM) signifies the presence of IgM antibodies against Ehrlichia chaffeensis in the patient's blood, typically indicating a recent or current infection with the bacterium. IgM antibodies are among the first to be produced in response to an infection and usually appear within the first couple of weeks after exposure. This makes the detection of elevated IgM levels particularly important in diagnosing acute cases of human monocytic ehrlichiosis (HME), a tick-borne illness caused by this bacterium. Patients with elevated IgM levels are likely in the early stages of the disease, which can present symptoms such as fever, headache, and muscle pain. However, it's important to interpret these results in the context of the patient's clinical presentation and history, including potential tick exposure, as IgM can sometimes persist for months after infection and cross-reactivity with other pathogens might lead to false positives. Therefore, an elevated E. Chaffeensis Ab (IgM) result, while indicative of a recent or ongoing infection, should be corroborated with other clinical and diagnostic information for accurate diagnosis and treatment.

Ehrlichia chaffeensis Ab (IgM) testing plays a critical role in the early diagnosis of human monocytic ehrlichiosis (HME), a tick-borne illness caused by the bacterium Ehrlichia chaffeensis. This test specifically looks for IgM antibodies, which are among the first antibodies produced by the immune system in response to an infection. The presence of IgM antibodies against E. chaffeensis typically indicates a recent or ongoing infection, as these antibodies usually develop within the first week or two after exposure to the bacterium and can be detected before the IgG antibodies.

In clinical practice, the E. chaffeensis Ab (IgM) test is particularly useful for diagnosing acute cases of HME, especially in patients presenting with early symptoms such as fever, headache, muscle pain, and possibly rash or gastrointestinal symptoms. A positive IgM test provides strong evidence of an active Ehrlichia chaffeensis infection, guiding immediate treatment and management. However, the presence of IgM antibodies can sometimes persist for months after the initial infection, so a positive result should be interpreted cautiously and in conjunction with other clinical findings and patient history, particularly regarding tick exposure. Additionally, false positives can occur due to cross-reactivity with antibodies from other infections. Therefore, while the detection of E. chaffeensis Ab (IgM) is a valuable indicator of a recent or current infection, it is essential to consider the entire clinical scenario, including symptom onset and progression, when making a diagnosis. Further confirmatory testing, such as polymerase chain reaction (PCR) tests, may be warranted in some cases to confirm the diagnosis.

E. Chaffeensis Ab IgM
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond E. Chaffeensis Ab IgM — 10,000+ markers explained
One E. Chaffeensis Ab IgM result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro